Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Cayla

Showing results (1-10 of 236) with videos related to

Pageof 24
Sort By:
JACC. Advances|June 28, 2024
Is Stent Thrombosis a Genetic Disease?Guillaume Cayla, Benoit Lattuca
Lancet (London, England)|March 30, 2017
ANTARCTIC: platelet function testing to adjust therapy - Authors' replyGilles Montalescot, Guillaume Cayla,
Journal of Thoracic Disease|September 8, 2022
Mechanical complications of acute myocardial infarction: a not "mechanical" preventive and therapeutic strategyBenoit Lattuca, Guillaume Cayla
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 5, 2023
De-escalation from potent P2Y12 inhibitors to clopidogrel: an alternative to short DAPT duration in HBR patients?Guillaume Cayla, Benoit Lattuca
Journal of the American College of Cardiology|December 21, 2019
Long-Term Outcomes on Multivessel Disease STEMI Patients: Which Is the Culprit Lesion?Guillaume Cayla, Benoit Lattuca
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 3, 2020
Which strategy should be the global leader in antithrombotic therapy decision making in older patients?Benoit Lattuca, Guillaume Cayla
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 20, 2025
DAPT de-escalation post-ACS: a new rule or just a new option? Lessons from the 4D-ACS trialThomas Cuisset, Guillaume Cayla
Archives of Cardiovascular Diseases|August 31, 2010
Clopidogrel resistance: what's new?Thomas Cuisset, Guillaume Cayla, Johanne Silvain
The New England Journal of Medicine|January 28, 2026
Aspirin in Patients Receiving Oral Anticoagulation. ReplyGilles Lemesle, Martine Gilard, Guillaume Cayla
Journal of the American College of Cardiology|January 29, 2021
Should Hemoglobin Drop Be Added to Bleeding Classifications in ACS?Olivier Barthélémy, Guillaume Cayla, Gilles Montalescot
Pageof 24

Showing results (1-10 of 236) with videos related to

Sort By:
Pageof 24
JACC. Advances|June 28, 2024
Is Stent Thrombosis a Genetic Disease?Guillaume Cayla, Benoit Lattuca
Lancet (London, England)|March 30, 2017
ANTARCTIC: platelet function testing to adjust therapy - Authors' replyGilles Montalescot, Guillaume Cayla,
Journal of Thoracic Disease|September 8, 2022
Mechanical complications of acute myocardial infarction: a not "mechanical" preventive and therapeutic strategyBenoit Lattuca, Guillaume Cayla
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 5, 2023
De-escalation from potent P2Y12 inhibitors to clopidogrel: an alternative to short DAPT duration in HBR patients?Guillaume Cayla, Benoit Lattuca
Journal of the American College of Cardiology|December 21, 2019
Long-Term Outcomes on Multivessel Disease STEMI Patients: Which Is the Culprit Lesion?Guillaume Cayla, Benoit Lattuca
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 3, 2020
Which strategy should be the global leader in antithrombotic therapy decision making in older patients?Benoit Lattuca, Guillaume Cayla
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 20, 2025
DAPT de-escalation post-ACS: a new rule or just a new option? Lessons from the 4D-ACS trialThomas Cuisset, Guillaume Cayla
Archives of Cardiovascular Diseases|August 31, 2010
Clopidogrel resistance: what's new?Thomas Cuisset, Guillaume Cayla, Johanne Silvain
The New England Journal of Medicine|January 28, 2026
Aspirin in Patients Receiving Oral Anticoagulation. ReplyGilles Lemesle, Martine Gilard, Guillaume Cayla
Journal of the American College of Cardiology|January 29, 2021
Should Hemoglobin Drop Be Added to Bleeding Classifications in ACS?Olivier Barthélémy, Guillaume Cayla, Gilles Montalescot
Pageof 24